Clinical features and outcomes of young patients with low‐grade non‐rhabdomyosarcoma soft tissue sarcomas treated with a risk‐based strategy: A report from Children's Oncology Group study ARST0332
Pediatric Blood & Cancer · 2024
DOI: 10.1002/pbc.31062 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von David P Douglass und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Hematology/Oncology, University of Arkansas for Medical Sciences, Arkansas Children's Hospital, Little Rock, Ar…. Hauptthemen laut MEDLINE: Sarcoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: St. Baldrick's Foundation, NCI NIH HHS, Children's Oncology Group Chair's Grant.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
In retrospective analyses, the Pediatric Oncology Group [POG) and the Federation National des Centres de Lutte Contre le Cancer (FNCLCC) histologic grade predict outcome in pediatric non‐rhabdomyosarcoma soft tissue sarcoma (NRSTS), but prospective data on grading, clinical features, and outcomes of low‐grade NRSTS are limited.
Methods
We analyzed patients less than 30 years of age enrolled on Children's Oncology Group (COG) study ARST0332 (NCT00346164) with POG grade 1 or 2 NRSTS. Low‐risk patients were treated with surgery alone. Intermediate‐/high‐risk patients received ifosfamide/doxorubicin and radiotherapy, with definitive resection either before or after 12 weeks of chemoradiotherapy.
Results
Estimated 5‐year event‐free and overall survival were 90% and 100% low risk ( n = 80), 55% and 78% intermediate risk ( n = 15), and 25% and 25% high risk ( n = 4). In low‐risk patients, only local recurrence was seen in 10%; none with margins greater than 1 mm recurred locally. Sixteen of 17 intermediate‐/high‐risk patients who completed neoadjuvant chemoradiotherapy underwent gross total tumor resection, 80% with negative margins. Intermediate‐/high‐risk group events included one local and seven metastatic recurrences. Had the FNCLCC grading system been used to direct treatment, 29% of low‐risk (surgery alone) patients would have received radiotherapy ± chemotherapy.
Conclusions
Most low‐risk patients with completely resected POG low‐grade NRSTS are successfully treated with surgery alone, and surgical margins greater than 1 mm may be sufficient to prevent local recurrence. Patients with intermediate‐ and high‐risk low‐grade NRSTS have outcomes similar to patients with high‐grade histology, and require more effective therapies. Use of the current FNCLCC grading system may result in overtreatment of low‐risk NRSTS curable with surgery alone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Hematology/Oncology, University of Arkansas for Medical Sciences, Arkansas Children's Hospital, Little Rock, Arkansas, USA.
- Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
- Department of Orthopaedic Surgery, University of California Davis Comprehensive Cancer Center, Sacramento, California, USA.
- Department of Population and Public Health Sciences, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.
- Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California, USA.
- Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
ORCID-Profile: David P Douglass, Donald A Barkauskas, M Beth McCarville, Alberto S Pappo, Aaron R Weiss, Sheri L Spunt
Förderung
- St. Baldrick's Foundation
- NCI NIH HHS
- Children's Oncology Group Chair's Grant
- Children's Oncology Group Imaging and Radiation Oncology Core
- American Lebanese Syrian Associated Charities
- Children's Oncology Group Quality Assurance Review Center
- NCTN Statistics & Data Center
- Children's Oncology Group Statistics and Data Center
Zitieren
APA
Douglass, D. P., Coffin, C. M., Randall, R. L., Yang, Y., Barkauskas, D. A., Million, L., McCarville, M. B., Pappo, A. S., Weiss, A. R., & Spunt, S. L. (2024). Clinical features and outcomes of young patients with low‐grade non‐rhabdomyosarcoma soft tissue sarcomas treated with a risk‐based strategy: A report from Children's Oncology Group study ARST0332. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31062
Vancouver
Douglass DP, Coffin CM, Randall RL, Yang Y, Barkauskas DA, Million L, et al. Clinical features and outcomes of young patients with low‐grade non‐rhabdomyosarcoma soft tissue sarcomas treated with a risk‐based strategy: A report from Children's Oncology Group study ARST0332. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.31062
BibTeX
@article{Douglass2024,
author = {Douglass, David P and Coffin, Cheryl M and Randall, R Lor and Yang, Yan and Barkauskas, Donald A and Million, Lynn and McCarville, M Beth and Pappo, Alberto S and Weiss, Aaron R and Spunt, Sheri L},
title = {Clinical features and outcomes of young patients with low‐grade non‐rhabdomyosarcoma soft tissue sarcomas treated with a risk‐based strategy: A report from Children's Oncology Group study ARST0332},
journal = {Pediatric Blood & Cancer},
year = {2024},
doi = {10.1002/pbc.31062}
}
EUVIMED